Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects

NCT05265676 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Enoxaparin Sodium (Venus Remedies Limited)
DRUG: Enoxaparin Sodium (Sanofi)

Sponsor

Venus Remedies Limited